To date, more sulphamoylated derivatives of 2ME have been developed110,111, including EM-191361 (Figure 7)112, which shows to be a potent STS inhibitor able to block tumour growth (MCF-7 xenograft) in nude mice.113. The gene discussed is STS; the disease is neoplasm.